mexiletine has been researched along with Injuries, Spinal Cord in 5 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mexiletine treatment improved early behavioral recovery after SCI." | 1.33 | Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury. ( Caner, H; Kaptanoglu, E; Kilinc, K; Solaroglu, I, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaptanoglu, E | 2 |
| Caner, H | 1 |
| Solaroglu, I | 1 |
| Kilinc, K | 1 |
| Ates, O | 1 |
| Cayli, SR | 1 |
| Gurses, I | 1 |
| Turkoz, Y | 1 |
| Tarim, O | 1 |
| Cakir, CO | 1 |
| Kocak, A | 1 |
| Caner, HH | 1 |
| Sürücü, HS | 1 |
| Akbiyik, F | 1 |
| Wu, WP | 1 |
| Nordmark, J | 1 |
| Wiesenfeld-Hallin, Z | 2 |
| Xu, XJ | 2 |
| Hao, JX | 1 |
| Seiger, A | 1 |
| Arnér, S | 1 |
| Lindblom, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Cohort Study of Association Between Steady State Phenytoin Treatment and Better Clinical Parameters of Glaucoma[NCT00739154] | 200 participants (Anticipated) | Observational | 2008-11-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for mexiletine and Injuries, Spinal Cord
| Article | Year |
|---|---|
Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury.
Topics: Animals; Behavior, Animal; Caspase 3; Caspases; Enzyme Activation; Female; Hindlimb; Methylprednisol | 2005 |
Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Lipid Peroxidation; Locomotion; Male; Mexiletine; | 2007 |
Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury.
Topics: Analysis of Variance; Animals; Antioxidants; Lipid Peroxidation; Male; Methylprednisolone Hemisuccin | 1999 |
Lack of stereoselectivity for the antiallodynic effect of mexiletine in spinally injured rats.
Topics: Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Female; | 2000 |
Systemic mexiletine relieves chronic allodynialike symptoms in rats with ischemic spinal cord injury.
Topics: Animals; Female; Injections, Intraperitoneal; Ischemia; Mexiletine; Motor Activity; Pain; Pain Measu | 1992 |